Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer
治疗原理和方案设计:一项研究者发起的II期临床研究,旨在评估纳武利尤单抗联合PAI-1抑制剂TM5614治疗既往接受过治疗的非小细胞肺癌患者的疗效。
期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-23-1858
Masuda, Takeshi; Hirata, Taizo; Sakamoto, Tomohiro; Tsubata, Yukari; Ichihara, Eiki; Kozuki, Toshiyuki; Shoda, Hiroyasu; Motonaga, Masanori; Yoshida, Takako; Fukutani, Miki; Tsuji-Takayama, Kazue; Tamura, Atsushi; Amagase, Harunobu; Fujihara, Hideki; Aoki, Gaku; Akita, Tomoyuki; Orihashi, Yasushi; Miyata, Toshio; Hattori, Noboru